-
Plasma DNA profile in DNASE1L3 deficiency
Dataset
EGAD00001006216
-
Neurodegenerative_TGS
Study
EGAS00001002431
-
H3K4me3, IgG, and Input ChIP-seq in overexpression of pLV Control, CS-FL and CS-ΔEx4 in SW1116 cells.
Study
EGAS00001008121
-
Swarm Learning to identify COVID-19, tuberculosis and leukemia patients based on blood transcriptomes
Dac
EGAC00001001639
-
summary
Dataset
EGAD00010001624
-
CDK4 phosphorylation predicts high sensitivity of malignant pleural mesotheliomas to CDK4/6 inhibition
Study
EGAS00001006117
-
Serum Proteome Profiling Identifies Early Markers of Therapeutic Response to Neoadjuvant Chemotherapy of Breast Cancer
Study
EGAS00001006228
-
CIDR: Discovery, Biology, and Risk of Inherited Variants in Glioma
Study
phs002250
-
Whole-genome DNA methylation profiling of CD14+ monocytes reveals disease status and activity differences in Crohn’s disease patients
Study
EGAS00001004221
-
Burden of Disease in Sarcoma
Dataset
EGAD00001000127
-
Whole Genome Methylation in CLL
Dataset
EGAD00001000177
-
Gene Discovery in Age-Related Hearing Loss
Dataset
EGAD00001000198
-
Screening for abnormal CGI methylation in primary colorectal tumours
Dataset
EGAD00001000213
-
ASD_cases
Dataset
EGAD00010002342
-
RNA-seq in insulinomas
Dataset
EGAD50000000462
-
DLBCLR
Study
EGAS00001007479
-
Follicular lymphoma at diagnosis, treated in first line with immunochemotherapy
Study
EGAS00001006674
-
RNAseq from blood CD34+ cells
Dataset
EGAD00001008194
-
Reduced-representation bisulfite sequencing generated from 2 glioblastoma cell lines subjected to hypoxic and irradiation stress
Dataset
EGAD00001007770
-
WGS,RNA data of patients with multiple myeloma (MM) refractory to immunomodulatory agents (IMiDs) and proteasome inhibitors (PIs)
Dataset
EGAD00001006189
-
UCL COVID-19 Single-cell PBMC
Dataset
EGAD00001007865
-
SNU_WGS_AML
Study
EGAS00001001906
-
SNU_PROSPECTIVE
Study
EGAS00001002154
-
Dataset for soft_tissue_tumor-RNA
Dataset
EGAD00001008859
-
Patient-Derived Follicular Lymphoma Spheroids recapitulate lymph node signaling and immune profile, uncovering galectin-9 as a novel immunotherapeutic target
Study
EGAS50000000233